You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
廣濟藥業(000952.SZ):子公司廣化製藥公開掛牌增資並放棄優先認購權
格隆匯 03-24 16:58

格隆匯3月24日丨廣濟藥業(000952.SZ)公佈,公司全資子公司湖北廣化製藥有限公司(簡稱“廣化製藥”)通過上海聯合產權交易所(簡稱“上海聯交所”)徵集並最終確認湖北省長江醫療產業投資有限公司(簡稱“長江醫療”)及黃岡高新產業投資集團有限公司(簡稱“黃岡高投”)爲其戰略投資方,增資金額分別爲20,000萬元和5,000萬元,新增註冊資本人民幣25,000萬元。公司在本次增資擴股中放棄優先認繳權。本次增資擴股完成後,廣化製藥註冊資本將變更爲35,000萬元,其中長江醫療持有廣化製藥57.14%股權,黃岡高投持有廣化製藥14.29%股權,公司持有廣化製藥28.57%股權,廣化製藥不再納入公司合併報表範圍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account